Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease
Pauline Caillard(Centre Hospitalier Universitaire Amiens-Picardie), Dimitri Titeca‐Beauport(Centre Hospitalier Universitaire Amiens-Picardie), Alexandre Ganea(Centre hospitalier universitaire d'Orléans), Morgane Heitz(Centre Hospitalier Universitaire de Grenoble), Mathilde Tamain(Institut Européen De La Qualité Totale), François Vrtovsnik(Assistance Publique – Hôpitaux de Paris), Alexandre Hertig(Sorbonne Université), Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Dominique Guerrot(Pediatric Nephrology of Alabama), Marion Rabant(Hôpital Necker-Enfants Malades), Marc Hazzan, Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Laurent Juillard, Vincent Audard(Inserm), Maïté Daroux(Université d'été de Boulogne-sur-Mer), Mathieu Legendre(CHU Dijon Bourgogne), Marie Essig, Jean-François Subra(Inserm), T. Quéméneur(Centre Hospitalier de Valenciennes), Éric Thervet(Hôpital Européen Georges-Pompidou), Vincent Vuiblet(Centre National pour la Recherche Scientifique et Technique (CNRST)), Marie‐Noelle Péraldi(Assistance Publique – Hôpitaux de Paris), Cécile Vigneau(Inserm), Raïfah Makdassi(Inserm), Thierry Lobbedez
Cited by 12
Related Papers
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363